Skip to content
OpenCapital
Get started

Kodiak Sciences Inc KOD EBIT

EBIT at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$116.17M-23.8%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$93.34M-46.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$53.42M-148%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$125.13M-119%
Immunome logo
ImmunomeIMNM
-$59.33M-32.9%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
——

Other financials

Income statement

See full
Operating income-$59.8M-1.2%
Net income-$58.2M-1.2%
EPS (diluted)-$0.94+13.8%

Balance sheet

See full
Cash & equivalents$169.5M+22.1%
Total debt$56.0M-17.2%
Total equity$112.1M+3.0%
Total assets$306.0M+2.7%

Cash flow

See full
Operating cash flow-$40.0M-37.6%
CapEx$942.0K+249%
Free cash flow-$41.0M-39.5%

Valuation

See full
Market cap$2.32B+1,477%
Enterprise value$2.2B+2,798%

Returns & leverage

See full
Return on equity-208.8%+2,306pp
Debt / equity0.5×-0.1×
Current ratio3.5×-1.1×

Where this comes from

Calculated from Kodiak Sciences Inc’s reported figures.

−$59.8Moperating income=-$59.78M

The official record: Kodiak Sciences Inc’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kodiak Sciences Inc's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kodiak Sciences Inc's EBIT?
Kodiak Sciences Inc (KOD) reported EBIT of -$59.78M in Q1 2026.
How has Kodiak Sciences Inc's EBIT changed year-over-year?
Kodiak Sciences Inc's EBIT decreased by 1.2% year-over-year, from -$59.07M to -$59.78M.
What is the long-term trend for Kodiak Sciences Inc's EBIT?
Over 4 years (2021 to 2025), Kodiak Sciences Inc's EBIT has grown at a -3.2% compound annual growth rate (CAGR), from -$267.05M to -$234.39M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.